Sean Lavin
Stock Analyst at BTIG
(3.08)
# 1,075
Out of 4,818 analysts
46
Total ratings
81.82%
Success rate
38.68%
Average return
Main Sectors:
Stocks Rated by Sean Lavin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TCMD Tactile Systems Technology | Downgrades: Neutral | n/a | $14.33 | - | 4 | Nov 5, 2024 | |
| HOLX Hologic | Downgrades: Neutral | n/a | $58.29 | - | 5 | Jul 18, 2022 | |
| PODD Insulet | Upgrades: Buy | $320 | $259.20 | +23.46% | 5 | Feb 3, 2022 | |
| MDT Medtronic | Downgrades: Neutral | n/a | $84.30 | - | 1 | Jan 10, 2022 | |
| ATRC AtriCure | Maintains: Buy | $42 → $48 | $33.75 | +42.22% | 3 | Feb 19, 2020 | |
| MASI Masimo | Downgrades: Neutral | n/a | $162.63 | - | 4 | Apr 16, 2019 | |
| HSDT Helius Medical Technologies | Downgrades: Neutral | n/a | $0.30 | - | 4 | Apr 16, 2019 | |
| IRTC iRhythm Technologies | Upgrades: Buy | $80 | $104.74 | -23.62% | 3 | Apr 3, 2019 | |
| NEO NeoGenomics | Upgrades: Outperform | n/a | $10.10 | - | 4 | Apr 16, 2018 | |
| EXAS Exact Sciences | Upgrades: Buy | n/a | $45.59 | - | 3 | Apr 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $129.39 | - | 1 | Jan 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.56 | - | 1 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $101.14 | - | 1 | Nov 30, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $70.78 | - | 3 | May 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $75.20 | - | 4 | Feb 2, 2017 |
Tactile Systems Technology
Nov 5, 2024
Downgrades: Neutral
Price Target: n/a
Current: $14.33
Upside: -
Hologic
Jul 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $58.29
Upside: -
Insulet
Feb 3, 2022
Upgrades: Buy
Price Target: $320
Current: $259.20
Upside: +23.46%
Medtronic
Jan 10, 2022
Downgrades: Neutral
Price Target: n/a
Current: $84.30
Upside: -
AtriCure
Feb 19, 2020
Maintains: Buy
Price Target: $42 → $48
Current: $33.75
Upside: +42.22%
Masimo
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $162.63
Upside: -
Helius Medical Technologies
Apr 16, 2019
Downgrades: Neutral
Price Target: n/a
Current: $0.30
Upside: -
iRhythm Technologies
Apr 3, 2019
Upgrades: Buy
Price Target: $80
Current: $104.74
Upside: -23.62%
NeoGenomics
Apr 16, 2018
Upgrades: Outperform
Price Target: n/a
Current: $10.10
Upside: -
Exact Sciences
Apr 3, 2018
Upgrades: Buy
Price Target: n/a
Current: $45.59
Upside: -
Jan 22, 2018
Downgrades: Neutral
Price Target: n/a
Current: $129.39
Upside: -
Dec 13, 2017
Downgrades: Neutral
Price Target: n/a
Current: $0.56
Upside: -
Nov 30, 2017
Upgrades: Buy
Price Target: n/a
Current: $101.14
Upside: -
May 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $70.78
Upside: -
Feb 2, 2017
Downgrades: Neutral
Price Target: n/a
Current: $75.20
Upside: -